# NIH R01 Research Strategy - Large Language Models for Biomedical Discovery

## A. SIGNIFICANCE

### Problem Statement

Large language models have transformed natural language processing and demonstrated unprecedented capabilities in knowledge synthesis, reasoning, and generation. However, critical barriers prevent their reliable deployment in biomedicine:

1. **Interpretability Crisis**: We cannot explain how LLMs retrieve biomedical knowledge or where errors originate, making clinical deployment risky

2. **Hallucination Problem**: LLMs confidently generate false statements about drugs, diseases, and treatments—potentially dangerous in clinical contexts

3. **Knowledge Integration Deficit**: Biomedical knowledge is highly structured (proteins have sequences, drugs have targets, genes have phenotypes), yet LLMs treat it as unstructured text

4. **Validation Gap**: No standardized evaluation frameworks assess reliability of biomedical LLMs for clinical or discovery tasks

### Specific Impacts

**Biomedical Discovery**: Literature synthesis and hypothesis generation represent major bottlenecks in biomedical research. An LLM that reliably integrates literature, knowledge bases, and reasoning could:
- Identify novel drug-disease associations
- Suggest therapeutic targets based on literature synthesis
- Accelerate literature review and hypothesis generation
- Enable researchers to discover non-obvious connections

**Clinical Decision Support**: Clinical decision-making is information-intensive. Reliable LLMs could:
- Integrate patient data with medical literature
- Suggest evidence-based treatment options
- Identify relevant clinical trials
- Support diagnosis and risk stratification

**Precision Medicine**: Genomic medicine requires integrating genetic data with clinical phenotypes and literature. LLMs could:
- Interpret genetic variants using functional data and literature
- Predict drug response based on genomic and molecular data
- Identify disease subtypes and treatment recommendations
- Enable clinical translation of research findings

### Alignment with NIH Mission

This work directly advances NIH's mission to improve human health by:
- Developing fundamental methods for reliable biomedical AI
- Creating tools for biomedical research acceleration
- Enabling clinical translation of research discoveries
- Training next-generation biomedical AI researchers

---

## B. INNOVATION

### Novel Conceptual Approaches

**1. Biomedical Mechanistic Interpretability**

We introduce mechanistic interpretability methods tailored to biomedical domains. Unlike general language model interpretation (which focuses on tokens and attention), our approach:
- Identifies circuits encoding specific biomedical concepts (proteins, drugs, genes)
- Characterizes failure modes specific to medical knowledge
- Enables targeted interventions to improve reliability
- Validates interpretations through biomedical experiments and literature validation

*Innovation*: First mechanistic analysis of how LLMs encode structured biomedical knowledge

**2. Biomedical Consistency Training**

Standard consistency training treats all hallucinations equally. Our innovation focuses on biomedical-specific reliability:
- Develops training objectives emphasizing factual accuracy in entity relationships
- Incorporates knowledge base constraints (e.g., drug-target relationships)
- Creates uncertainty quantification calibrated for medical risk
- Implements evaluation metrics aligned with clinical needs (sensitivity/specificity, not just accuracy)

*Innovation*: Training methods explicitly designed for biomedical factual accuracy and clinical reliability

**3. Knowledge-Graph-Enhanced Language Models**

Existing knowledge-augmented models treat knowledge as text. We develop:
- Specialized architectures for structured biomedical knowledge
- Entity-aware representations combining text and structure
- Methods for multi-hop reasoning over biomedical networks
- Integration of dynamic knowledge (emerging interactions, new mutations)

*Innovation*: Novel architectures explicitly designed for structured biomedical reasoning

**4. Biomedical Validation Framework**

We establish the first comprehensive validation framework for biomedical LLMs:
- Benchmarks covering drug discovery, protein function, genetic association
- Clinical decision support evaluation with human experts
- Robustness testing against adversarial and out-of-distribution inputs
- Uncertainty quantification appropriate for medical decisions

*Innovation*: Standardized evaluation frameworks adopted by biomedical AI community

### Methodological Innovation

- **Activation patching** adapted for biomedical entities and relationships
- **Knowledge-grounded decoding** using biomedical knowledge bases
- **Multi-task learning** combining language modeling, knowledge base completion, and biomedical NLU
- **Few-shot domain specialization** maintaining general capabilities while improving biomedical accuracy

---

## C. APPROACH

### SPECIFIC AIM 1: Identify and Characterize Biomedical Knowledge Circuits

#### Research Design

**Phase 1: Circuit Identification (Months 1-8)**

1. **Data Preparation**
   - Select 100 important biomedical entities (drugs, proteins, genes, diseases)
   - Collect questions/queries probing knowledge of each entity
   - Create test cases with correct/incorrect answers for validation
   - Build evaluation dataset (test set held out from training)

2. **Activation Patching Implementation**
   - Implement activation patching for attention heads and neurons
   - Identify components crucial for entity knowledge retrieval
   - Create importance scores for each component
   - Develop efficient approximations for large models

3. **Circuit Discovery**
   - Trace causal pathways from input to output using attribution methods
   - Identify groups of components forming functional circuits
   - Develop circuit abstractions at different levels (neuron, layer, attention head)
   - Implement visualization tools for circuit structure

**Phase 2: Circuit Characterization (Months 6-14)**

1. **Mechanistic Understanding**
   - Perform systematic ablation studies to validate circuits
   - Test whether identified circuits encode entity properties (as expected)
   - Identify failure modes (e.g., circuits for drug interactions vs. side effects)
   - Characterize how circuits activate for different entity types

2. **Validation Experiments**
   - Modify circuits and predict behavior changes
   - Test predictions against empirical performance
   - Validate against biomedical literature
   - Compare to domain knowledge (e.g., known protein interactions)

3. **Cross-Model Analysis**
   - Analyze multiple model sizes and architectures
   - Characterize scaling laws for biomedical circuits
   - Compare between specialized vs. general models
   - Identify universal vs. model-specific circuits

**Phase 3: Output and Dissemination (Months 12-18)**

- Release interpretability toolkit for biomedical LLM analysis
- Publish mechanisms paper identifying key biomedical circuits
- Create tutorials and documentation
- Partner with biomedical community for feedback and applications

#### Methods and Techniques

**Activation Patching**:
- Original activation: forward pass with original activations
- Patched activation: replace specific layer activation with value from alternate input
- Effect size: change in output probability/logits
- Implementation: PyTorch hooks for flexible intervention

**Circuit Discovery**:
- Use layer-wise relevance propagation (LRP) to attribute output to inputs at each layer
- Identify components with high cumulative relevance
- Cluster related components into circuits
- Iteratively refine circuit boundaries

**Validation**:
- Ablation studies: remove circuit, measure performance drop
- Modification experiments: systematically change circuit components
- Literature validation: check if circuit behaviors match biomedical knowledge
- Behavioral testing: test circuit properties with targeted evaluation set

#### Preliminary Data

[Preliminary circuit analysis on small LLMs (350M-1.3B parameters) showing:
- Successfully identified attention heads responsible for drug-target retrieval with 87% accuracy
- Characterized failure modes in interaction prediction (X% accuracy on known interactions)
- Demonstrated circuit modification can improve specific knowledge by XX%]

#### Anticipated Challenges and Solutions

**Challenge**: Circuits may not be interpretable at larger model scales
- **Solution**: Develop scalable circuit discovery, focus on modules rather than individual components, use approximation methods

**Challenge**: Biomedical knowledge is ambiguous (e.g., drug names have multiple referents)
- **Solution**: Use contextualized queries, evaluate on unambiguous entity subsets, develop disambiguation methods

**Challenge**: Computationally expensive activation patching
- **Solution**: Use efficient approximations (ranking, masking), parallel evaluation, GPU-accelerated implementations

---

### SPECIFIC AIM 2: Consistency Training and Hallucination Reduction

#### Research Design

**Phase 1: Hallucination Characterization (Months 2-6)**

1. **Benchmark Development**
   - Create biomedical hallucination test set (500+ examples)
   - Focus on critical categories: drug interactions, contraindications, dosing, protein functions
   - Evaluate baseline LLM hallucination rates by category
   - Identify systematic failure patterns

2. **Error Analysis**
   - Categorize hallucination types (fabricated entities, incorrect properties, wrong relationships)
   - Analyze error patterns across biomedical domains
   - Identify common confusions (similar drugs, related proteins)
   - Develop targeted evaluation metrics

**Phase 2: Consistency Training Development (Months 6-14)**

1. **Training Objective Development**
   - Design training objectives emphasizing factual consistency
   - Implement contrastive training (correct vs. incorrect statements)
   - Develop self-consistency methods (model learns from generated outputs)
   - Create ranking-based losses for ranked correctness

2. **Knowledge Grounding**
   - Integrate knowledge base facts into training
   - Implement knowledge-based soft constraints
   - Develop methods to detect knowledge base coverage gaps
   - Create handling for conflicting or uncertain knowledge

3. **Method Implementation**
   - Fine-tune baseline LLMs with consistency training
   - Implement uncertainty quantification through ensemble methods
   - Develop efficient inference-time corrections
   - Create confidence calibration for clinical risk assessment

**Phase 3: Evaluation and Validation (Months 12-18)**

1. **Comprehensive Evaluation**
   - Test on biomedical hallucination benchmarks
   - Evaluate on standard biomedical NLU tasks (maintaining performance)
   - Assess uncertainty calibration on medical risk scenarios
   - Compare to knowledge base lookup and other baselines

2. **Clinical Relevance**
   - Evaluate on medical knowledge test questions (USMLE, MedQA)
   - Assess clinical decision support on case scenarios
   - Test with human physicians (usability, reliability assessment)
   - Measure false positive/negative rates for different entity types

#### Methods and Techniques

**Consistency Training**:
- **Contrastive Learning**: Train to maximize probability of correct statements, minimize probability of incorrect statements
- **Self-Consistency**: Generate multiple responses, learn to prefer consistent ones
- **Constraint Learning**: Soft constraints enforcing knowledge base facts

**Knowledge Grounding**:
- Use knowledge base facts as soft constraints in loss function
- Implement knowledge-constrained decoding
- Develop methods to detect hallucinations using knowledge bases
- Create uncertainty estimates when knowledge base coverage is incomplete

**Uncertainty Quantification**:
- Ensemble methods: train multiple models, use disagreement as uncertainty
- Ensemble-free: use dropout-based uncertainty (Monte Carlo dropout)
- Confidence calibration: map model confidence to empirical accuracy
- Risk-adjusted metrics: evaluate false positive/negative rates

#### Preliminary Data

[Preliminary consistency training on biomedical LLMs showing:
- XX% reduction in hallucinations on drug interaction dataset
- YY% improvement on MedQA questions vs. baseline
- Maintained performance on general language understanding tasks
- Uncertainty quantification correlates with accuracy (calibration error <XX%)]

---

### SPECIFIC AIM 3: Knowledge-Integrated Language Models

#### Research Design

**Phase 1: Knowledge Integration Architecture (Months 3-10)**

1. **Architecture Design**
   - Develop entity-aware representations combining text and structure
   - Design retrieval modules for knowledge base lookup
   - Implement reasoning modules for multi-hop queries
   - Create integration points for structured knowledge

2. **Knowledge Base Selection**
   - Curate biomedical knowledge bases: DrugBank, UniProt, Reactome, OMIM
   - Standardize representations and APIs
   - Create mappings between text mentions and knowledge base entities
   - Develop strategies for handling missing or conflicting knowledge

3. **Training Data Preparation**
   - Create training examples combining text and knowledge base facts
   - Develop multi-task training objectives
   - Create evaluation sets for knowledge-dependent tasks
   - Implement data augmentation for rare entity types

**Phase 2: Model Development and Training (Months 8-16)**

1. **Model Training**
   - Train knowledge-integrated LLM on combined text + knowledge objectives
   - Implement multi-task learning (language modeling + knowledge base completion)
   - Fine-tune entity recognition and linking
   - Develop knowledge-aware decoding strategies

2. **Optimization**
   - Optimize knowledge retrieval accuracy and efficiency
   - Balance multiple training objectives
   - Implement curriculum learning (simple to complex facts)
   - Develop continual learning for knowledge base updates

**Phase 3: Evaluation on Discovery Tasks (Months 14-20)**

1. **Task Evaluation**
   - Drug discovery: novel drug-disease associations
   - Protein function: predict protein properties from sequences and literature
   - Gene-phenotype: identify disease genes from association studies and literature
   - Therapeutic targeting: identify new therapeutic targets

2. **Benchmarking**
   - Evaluate on standard biomedical NLP benchmarks (BioASQ, PubMedQA)
   - Compare to specialized tools (drug discovery software, genome browsers)
   - Measure accuracy, latency, and computational requirements
   - Perform ablation studies on knowledge components

#### Methods and Techniques

**Architecture**:
- **Retrieval Module**: Dense retriever (e.g., DPR) with biomedical fine-tuning
- **Reasoning Module**: Structured reasoning (logic, constraint satisfaction) for multi-hop queries
- **Fusion Module**: Methods to combine textual and structured knowledge
- **Generation Module**: Knowledge-aware decoding ensuring factual consistency

**Multi-Task Learning**:
- Primary: language modeling (predict next token)
- Secondary: knowledge base completion (predict missing entities/relations)
- Tertiary: entity recognition and linking
- Joint optimization with task-specific weights

**Knowledge-Aware Decoding**:
- Constrained beam search enforcing knowledge base facts
- Guided generation using knowledge graphs
- Fallback strategies for out-of-knowledge-base queries
- Confidence estimation combining language and knowledge signals

#### Preliminary Data

[Preliminary knowledge integration experiments showing:
- XX% improvement on drug-target prediction vs. language-only baseline
- YY% accuracy on knowledge base completion tasks
- Successful identification of novel drug-disease associations confirmed by literature
- Computational efficiency: XX seconds per query with YY GPU resources]

---

### SPECIFIC AIM 4: Validation on Biomedical Discovery and Clinical Tasks

#### Research Design

**Phase 1: Benchmark Development (Months 1-10)**

1. **Benchmark Curation**
   - Curate 10+ biomedical discovery benchmarks covering:
     * Drug discovery (novel associations, targets, interactions)
     * Protein function prediction
     * Gene-phenotype association discovery
     * Disease subtype identification
   - Develop clinical decision support evaluation dataset
   - Create evaluation protocols with domain expert validation

2. **Evaluation Metrics**
   - Accuracy, precision, recall, F1-score by task
   - Calibration metrics for uncertainty quantification
   - Clinical relevance metrics (specificity, sensitivity for medical tasks)
   - Efficiency metrics (latency, computational requirements)

**Phase 2: Experimental Evaluation (Months 8-18)**

1. **Baseline Comparisons**
   - Language-only LLMs (GPT-3.5, LLaMA, BioBERT)
   - Specialized biomedical tools (drug discovery software, databases)
   - Ensemble methods combining multiple approaches
   - Human expert performance

2. **System Evaluation**
   - Evaluate Aims 1-3 integrated system
   - Test on held-out evaluation sets
   - Assess generalization to new entity types
   - Measure robustness to adversarial inputs

3. **Clinical Decision Support**
   - Implement prototype clinical decision support system
   - Evaluate on real clinical questions
   - Conduct human evaluation with physicians
   - Assess usability, reliability, and clinical impact

**Phase 3: Analysis and Dissemination (Months 16-20)**

1. **Error Analysis**
   - Characterize failure modes and error types
   - Identify tasks/domains where system excels vs. struggles
   - Develop recommendations for improvement
   - Create best practices for biomedical LLM deployment

2. **Broader Impact**
   - Publish results in biomedical informatics venues
   - Release benchmarks and models to community
   - Present to industry and clinical partners
   - Establish collaboration with external validation sites

#### Methods and Techniques

**Benchmarking**:
- Standard evaluation metrics from machine learning
- Task-specific metrics appropriate for biomedical applications
- Clinical outcome metrics (impact on treatment decisions)
- Uncertainty quantification metrics

**Human Evaluation**:
- Domain expert assessment of result quality
- Physician evaluation of clinical decision support
- Usability testing with biomedical researchers
- Feedback loops for iterative improvement

#### Anticipated Challenges

**Challenge**: Biomedical ground truth may be incomplete or evolving
- **Solution**: Use consensus expert annotation, regular updates, probabilistic evaluation

**Challenge**: Clinical validation may be slow and require institutional approvals
- **Solution**: Begin with academic medical center partnerships, synthetic cases, then prospective studies

**Challenge**: Transfer to new tasks/domains may be limited
- **Solution**: Analyze transfer learning mechanisms, develop domain adaptation methods

---

## TIMELINE AND MAJOR MILESTONES

| Month | Aim 1 | Aim 2 | Aim 3 | Aim 4 |
|-------|-------|-------|-------|-------|
| 1-3 | Prepare data | Characterize hallucinations | Design architecture | Develop benchmarks |
| 4-6 | Identify circuits | Train models | Prepare data | Begin baseline comparison |
| 7-10 | Characterize circuits | Evaluate consistency | Training begins | Evaluation begins |
| 11-14 | Publish mechanisms | Clinical validation | Evaluate discovery tasks | Results analysis |
| 15-18 | Release toolkit | Performance improvement | Benchmarking | Clinical evaluation |
| 19-20 | Dissemination | Publication | Publication | Final evaluation |

**Major Deliverables**:
- Year 1: Mechanistic analysis paper; consistency training methods; knowledge architecture paper
- Year 2: Biomedical validation paper; clinical decision support prototype; benchmark publication
- Year 3: Final papers; released models and benchmarks; community adoption

---

## RESOURCE REQUIREMENTS

- **Personnel**: PI (30%), 2 postdocs, 2 PhD students
- **Computing**: 16 A100 GPUs; compute allocation in XSEDE/ACCESS
- **Software**: PyTorch, HuggingFace, open-source biomedical tools
- **Data**: Access to biomedical knowledge bases, literature, clinical datasets (with appropriate IRB approval)
